Monkeypox: the DGS recommends the vaccine for high-risk contacts – News

The standard published today by the General Directorate of Health (DGS) relating to vaccination against infection by the monkeypox virus (VMPX), responsible for monkeypox, recommends the vaccine “to date, in a context of post- exposure, i.e. to people identified as close contacts of reported cases, as this may prevent or alleviate clinical manifestations
of human infection with Monkeypox virus.

Contacts at risk who wish to be vaccinated must do so “within the first four days of the last close contact with a case, and this period can be up to 14 days if the person remains asymptomatic”, establish the health authorities.

“Close contacts must be reported after notification of a suspected case so that they can be contacted individually and a declaration issued for vaccination at one of the vaccination points defined by each health region”, continues the DGS, which reinforces ” the importance of identifying people who have been in close contact with the diagnosed cases, as quickly as possible, so that vaccination can be directed.

It is recalled that, on July 6, the National Medicines Authority (Infarmed) granted an exceptional use authorization in Portugal for the smallpox vaccine approved in the United States also for Monkeypox. The latest smallpox vaccine is an attenuated, non-replicating strain of vaccinia virus (MVA), approved in the European Union since July 2013 for protection against smallpox in adults.

At the beginning of July, Portugal received the first 2,700 doses of vaccines against the Monkeypox virus, acquired by the European Commission for distribution to the Member States most affected by the epidemic.

The DGS recalls that a sick person is no longer contagious until after complete healing and crusting of the skin lesions, a period possibly exceeding four weeks.

The most common symptoms of the disease are fever, severe headache, muscle pain, back pain, fatigue, enlarged lymph nodes with the gradual appearance of rashes that affect the skin and joints. mucous membranes.

Add Comment